Indefinite Delivery Contract SPE2DX15D3517

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, which runs through November 2026, serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers an extensive array of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, and infectious disease prevention.

Under this IDC, the DLA has issued numerous firm fixed-price delivery orders to AmerisourceBergen for the supply of various pharmaceutical and medical products, including medications like Fentanyl, Phenylephrine, Rocuronium, Meloxicam, Valtrex, Bridion, and Fluticasone Propionate. These delivery orders, which do not utilize any set-aside designations, enable the DLA to efficiently procure essential healthcare commodities to meet the needs of military personnel, veterans, and other federal beneficiaries. The contract's single-award structure and comprehensive scope demonstrate AmerisourceBergen's ability to serve as a key supplier of medical products and pharmaceuticals to the U.S. federal government.